Skip to content

Clinical trials

Adenoviridae Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoviridae Infections Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20054
20063
20076
20082
20097
20104
20119
20128
20136
20148
20154
20166
20177
20185
20196
20202
20219
20226
20233
20247
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting22
Unknown status21
Terminated13
Withdrawn8
Active, not recruiting4
Not yet recruiting4
Enrolling by invitation3
No longer available2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)10
Baylor College of Medicine7
AlloVir6
Jazz Pharmaceuticals6
Assistance Publique - Hôpitaux de Paris4
ReiThera Srl4
McMaster University3
Beijing Bio-Targeting Therapeutics Technology Co., Ltd2
CG Oncology, Inc.2
Children's Hospital Medical Center, Cincinnati2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoviridae Infections136
Cytomegalovirus Infections23
Epstein-Barr Virus Infections22
Virus Diseases12
Prostatic Neoplasms7
HIV Infections6
Influenza, Human5
Neoplasms5
Coronavirus Infections4
Enterovirus Infections4

Trials

Showing 26 to 50 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.